FdaApplication
ANDA 213829
Identifiers
- fda_app_no: ANDA213829
Properties
| Property | Value |
|---|---|
| applicant_name | SOMERSET THERAPEUTICS LLC |
| application_type | ANDA |
| approval_date | 2021-08-13 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEUPROLIDE ACETATE | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION;SUBCUTANEOUS |
1 product